Annex
United Kingdom
- A..
Annex I to Regulation (EEC) No 2377/90 is amended as follows:
- 1..
Anti-infectious agents
- 1.2.
Antibiotics
- 1.2.2.
Cephalosporins
Pharmacologically active substance Marker residue Animal species MRLs Target tissues Other provisions ‘1.2.2.2.
Cefazolin
Cefazolin Bovine 50 μg/kg Milk’
- 1.2.2.
- 1.2.
- 2..
Anti-parasitic agents
- 2.3.
Agents acting against endo- and ectoparasites
- 2.3.1.
Avermectins
Pharmacologically active substance Marker residue Animal species MRLs Target tissues Other provisions ‘2.3.1.3.
Doramectin
Doramectin Bovine 150 μg/kg Fat 100 μg/kg Liver 30 μg/kg Kidney 10 μg/kg Muscle’
- 2.3.1.
- 2.3.
- 1..
- B..
Annex II is amended as follows:
- 2..
Organic compounds
Pharmacologically active substance(s) Animal species Other provisions ‘2.75.
Alfaprostol
Bovine, porcine, equidae 2.76.
Cefazolin
Bovine For intramammary use only (except if the udder maybe used as food for human consumption). 2.77.
Medroxyprogesterone acetate
Ovine For intravaginal use for zootechnical purposes only 2.78.
Propylene glycol
All food producing species’
- 2..
- C..
Annex III is amended as follows:
- 1..
Anti-infectious agents
- 1.2.
Antibiotics
- 1.2.4.
Cephalosporins
Pharmacologically active substance Marker residue Animal species MRLs Target tissues Other provisions ‘1.2.4.2.
Cephapirin
Sum of cephapirin and desacetylcephapirin Bovine 100 μg/kg Kidney Provisional MRLs expire on 1. 1. 1999 50 μg/kg Muscle, liver, fat 10 μg/kg Milk’
- 1.2.4.
- 1.2.
- 1..
- D..
Annex IV is amended as follows:
List of pharmacologically active substances for which no maximum levels can be fixed:
‘9.
Chloroform’